Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: IRAPs (Secreted Insulin Regulated AminoPeptidase): a New Insulin Sensitivity Biomarker [NA]

View source ↗

Summary

A completed clinical trial evaluating IRAPs (secreted insulin-regulated aminopeptidase) as a biomarker of insulin sensitivity in individuals with insulin resist…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Insulin Resistance | NA | Status: COMPLETED